Operator
Hello, everyone. Thank you for joining us, and welcome to the BioHarvest Sciences Fourth Quarter and Year-End 2025 Earnings Call. [Operator Instructions]
I will now hand the call over to Justin Meiklem, Head of Investor Relations. Please go ahead.
Justin Meiklem
Greetings. With us on the call are Dr. Zaki Rakib, Chairman; Ilan Sobel, Chief Executive Officer; and Bar Dichter, Chief Financial Officer.
Before we begin, I’d like to remind you that management will be making projections and forward-looking statements on the call today regarding future events. Any statements that are not historical facts are forward-looking statements. These statements are made pursuant to and within the meaning of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. We encourage you to review BioHarvest Sciences’ SEC filings, including the company’s most recent Form 40-F, which identify risks and uncertainties that may cause future actual results or events to differ materially. These filings can be found on the company website, as well as the SEC’s website at www.sec.gov. Please note that the forward-looking statements made during today’s call speak only to the date they are made, and BioHarvest Sciences undertakes no obligation to update them.
And with that, I would like to now turn the call over to Ilan Sobel, Chief Executive Officer. Ilan?